User profiles for M. Bourdenx

Mathieu Bourdenx

UK Dementia Research Institute at University College London
Verified email at ucl.ac.uk
Cited by 3076

[PDF][PDF] The different autophagy degradation pathways and neurodegeneration

A Fleming, M Bourdenx, M Fujimaki, C Karabiyik… - Neuron, 2022 - cell.com
The term autophagy encompasses different pathways that route cytoplasmic material to
lysosomes for degradation and includes macroautophagy, chaperone-mediated autophagy, and …

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

…, M Bourdenx, P Gorry, S Przedborski, M Vila… - The Lancet …, 2015 - thelancet.com
Progressive neuronal cell loss in a small subset of brainstem and mesencephalic nuclei and
widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy …

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

…, G Fisone, AJ Stoessl, M Bourdenx, M Engeln… - Progress in …, 2015 - Elsevier
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-dopa)
therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately …

[PDF][PDF] Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome

M Bourdenx, A Martín-Segura, A Scrivo… - Cell, 2021 - cell.com
Components of the proteostasis network malfunction in aging, and reduced protein quality
control in neurons has been proposed to promote neurodegeneration. Here, we investigate …

[HTML][HTML] Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice

B Caballero, M Bourdenx, E Luengo, A Diaz… - Nature …, 2021 - nature.com
Disrupted homeostasis of the microtubule binding protein tau is a shared feature of a set of
neurodegenerative disorders known as tauopathies. Acetylation of soluble tau is an early …

Selective autophagy as a potential therapeutic target for neurodegenerative disorders

A Scrivo, M Bourdenx, O Pampliega… - The Lancet …, 2018 - thelancet.com
Cells rely on surveillance systems such as autophagy to handle protein alterations and
organelle damage. Dysfunctional autophagy, an evolutionarily conserved cellular mechanism for …

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

ML Arotcarena, S Dovero, A Prigent, M Bourdenx… - Brain, 2020 - academic.oup.com
In Parkinson’s disease, synucleinopathy is hypothesized to spread from the enteric nervous
system, via the vagus nerve, to the CNS. Here, we compare, in baboon monkeys, the …

Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases

M Bourdenx, J Daniel, E Genin, FN Soria… - Autophagy, 2016 - Taylor & Francis
… Colocalization was observed after 24 h incubation ((L) and M). Orthogonal projection of
stack image and 3D reconstruction show PLGA-aNP surrounded by LAMP1-GFP signal ((M)and …

[HTML][HTML] Proteome-wide analysis of chaperone-mediated autophagy targeting motifs

P Kirchner, M Bourdenx, J Madrigal-Matute… - PLoS …, 2019 - journals.plos.org
… PK was supported by a DFG KI 1992/1-1 postdoctoral fellowship; JM-M is supported by
postdoctoral fellowship 17POST33650088 from the American Heart Association and is a Leducq …

Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies

M Bourdenx, NS Koulakiotis, D Sanoudou… - Progress in …, 2017 - Elsevier
Alzheimer's and Parkinson's diseases are the most prevalent neurodegenerative diseases
that generate important health-related direct and indirect socio-economic costs. They are …